유방암종에서 p27kip1 단백의 세포 내 발현 위치와 예후와의 관련성 = Subcellular Localization of p27kip1 in Breast Cancer and Its Prognostic Significance

다국어 초록 (Multilingual Abstract)

Background : p27 is a member of the cyclin-dependent kinase (CDK)inhibitors that arrest the progression of the cell cycle; thus, it acts as a tumor suppressor gene. The loss or decrease of p27 protein is frequently seen and this has an independent prognostic potential for many human cancers. p27 is functionally inactivated through accelerated proteolysis and cytoplasmic sequestration. Cytoplasmic mislocalization of p27 by abnormal phosphorylation in the
tumor cells doesn’t allow it to bind and inhibit nuclear cyclin/CDK targets. Methods : We examined
the p27 protein expression in 86 cases of invasive ductal carcinoma of the breast via immunohistochemical staining to evaluate the subcellular localization of p27 and its relationship with the clinicopathologic features and the prognostic factors. Results : The nuclear expression of p27 was noted in 48.9% of the tumors, a combined nuclear and cytoplasmic expression
was noted in 20.9%, a cytoplasmic expression was noted in 12.8%, and a negative expression was noted in 17.4%. The decreased nuclear expression and/or cytoplasmic mislocalization of p27 were statistically correlated with the nuclear grade (p=0.001), histologic grade (p=0.036), tumor size (p=0.033), lymph node metastasis (p=0.043), ER (p=0.001), and PR (p=0.001) status, while they were not correlated with patient age, stage, HER2, p53, and Ki67. Conclusions : The breast tumors showing both decreased nuclear expression and cytoplasmic mislocalization of p27 are associated with a deranged cell cycle via functional inactivation and also with poor prognostic factors. It is expected that p27 can be a promising anticancer target molecule for the treatment of breast cancer.

참고문헌 (Reference)

1 "The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition" 278 : 23441-23450, 2003

2 "The prognostic significance of p27 and cyclin E in human breast cancer" 1 : 241-250, 1998

3 "The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas" 57 : 1259-1263, 1997

4 "Significance of the expression of p27Kip1 protein in human breast cancer" 5 : 291-297, 2002

5 "Prognostic role of p27Kip1 and apoptosis in human breast cancer" 79 : 1572-1578, 1999

6 "Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin during G1 and prevents nuclear re-entry" 280 : 6055-6063, 2005

7 "PKB/Akt phosphorylates p27,impairs nuclear import of p27 and apposes p27-mediated G1 arrest" 8 : 1153-1160, 2002

8 "P27kip1 expression in breast carcinomas:an immunohistochemical study on 512 patients with long-term follow-up" 89 : 236-241, 2000

9 "P27kip1 downregulation is associated with trastuzumab resistance in breast cancer cells" 64 : 3981-3986, 2004

10 "Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells" 104 : 865-874, 1999

11 "Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27" 275 : 24735-24739, 2000

12 "Novel p27kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions" 23 : 216-228, 2003

13 "Multiple functions of p27Kip1 and its alterations in tumor cells:a review" 183 : 18-27, 2000

14 "Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors" 85 : 707-720, 1996

15 "Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma" 94 : 973-979, 2002

16 "Localization and expression of p27Kip1 in multistage colorectal carcinogenesis" 58 : 114-122, 1998

17 "Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells" 579 : 3932-3940, 2005

18 "Immunohistochemical study of p27Kip1 expression ingastric adenomas and early gastric carcinoma -analysis of 65 cases-" 37 : 325-332, 2003

19 "High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin" 21 : 3594-3600, 2003

20 "High level expression of p27kip1 and cyclin D1 in some human breast cancer cells:inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers" 94 : 6380-6385, 1997

21 "High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas:relation to E-cadherin alterations,proliferative activity,and ploidy of the tumors" 94 : 2454-2465, 2002

22 "Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer" 59 : 3790-2794, 1999

23 "Expression of p34cdc2,p27Kip1,p21WAR1/Cip1 and p53 in human breast cancers" 39 : 391-400, 2005

24 "Expression of p27kip1 in breast cancer and its prognostic significance" 201 : 451-459, 2003

25 "Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status:results from international breast cancer study group trial V" 97 : 1591-1600, 2003

26 "Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer" 8 : 1136-1144, 2002

27 "Cyclin E,p27 and mutant p53 donot predict the prognosis in AJCC stage II colorectal carcinomas" 44 : 314-20, 2004

28 "Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer" 3 : 1074-1080, 2004